MarketCap
Facebook
X
Telegram
Land |
 Niederlande |
IPO-Jahr |
2016 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
64.2 M |
Marktkapitalisierung |
$ 5.78 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market |  USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market |  Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.21 | 5.22 % | $ 7.62 M | Nasdaq Capital Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 1.12 | 1.82 % | $ 112 M | Nasdaq Global Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 12.37 | 0.75 % | $ 3.7 B | Nasdaq Global Select Market | Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 58.37 | 0.41 % | $ 7.81 B | Nasdaq Global Select Market,SPB | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 55.14 | 1.4 % | $ 10.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Celldex Therapeutics
CLDX
|
$ 27.84 | 0.46 % | $ 1.85 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 4.13 | 4.42 % | $ 50.4 M | Nasdaq Capital Market |  Israel |
 |
Jaguar Health
JAGX
|
$ 4.18 | 0.48 % | $ 9.75 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.61 | 0.36 % | $ 205 M | NYSE American | Israel |
 |
uniQure N.V.
QURE
|
$ 20.97 | 1.72 % | $ 1.21 B | Nasdaq Global Select Market | Niderland |
 |
Stoke Therapeutics
STOK
|
$ 23.26 | 3.38 % | $ 1.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Xencor
XNCR
|
$ 23.39 | 0.17 % | $ 1.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Annexon
ANNX
|
$ 3.67 | 0.52 % | $ 569 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.93 | 1.54 % | $ 3.18 M | NYSE American | Israel |
 |
Incyte Corporation
INCY
|
$ 111.57 | 2.72 % | $ 21.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 13.79 | 0.11 % | $ 16.7 B | Nasdaq Global Select Market |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.41 | 0.28 % | $ 757 M | Nasdaq Global Select Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 498.5 | 2.74 % | $ 127 B | Nasdaq Global Select Market,SPB | USA |
 |
AbbVie
ABBV
|
$ 283.48 | 3.32 % | $ 501 B | NYSE,SPB | USA |
 |
Abeona Therapeutics
ABEO
|
$ 4.36 | 0.1 % | $ 231 M | Nasdaq Capital Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.38 | 1.11 % | $ 414 M | Nasdaq Global Select Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.19 | 1.95 % | $ 803 M | Nasdaq Global Select Market | Canada |
 |
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Achieve Life Sciences
ACHV
|
$ 7.0 | 0.21 % | $ 305 M | Nasdaq Capital Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 25.62 | 1.34 % | $ 3.89 B | Nasdaq Global Select Market,SPB | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 1.7 | 1.19 % | $ 96.7 M | Nasdaq Global Select Market,SPB | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market |  Irlanda |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |